Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Yale Cancer Center/Smilow Cancer Hospital.
J Natl Compr Canc Netw. 2022 Jun;20(6):691-722. doi: 10.6004/jnccn.2022.0030.
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.
对于非浸润性或浸润性乳腺癌患者,治疗选择复杂多样。这些 NCCN 乳腺癌临床实践指南包括对原位癌、浸润性乳腺癌、派杰病、叶状肿瘤、炎性乳腺癌患者的临床管理建议,以及妊娠期间乳腺癌的管理建议。本期内容重点介绍了导管原位癌整体管理建议,以及早期浸润性乳腺癌的检查和局部区域管理建议。欲了解 NCCN 乳腺癌指南全文,请访问 NCCN.org。
J Natl Compr Canc Netw. 2022-6
J Natl Compr Canc Netw. 2024-7
J Natl Compr Canc Netw. 2018-3
J Natl Compr Canc Netw. 2021-5-1
J Natl Compr Canc Netw. 2010-7
J Natl Compr Canc Netw. 2023-6
J Natl Compr Canc Netw. 2020-3
Cancer Control. 2001
J Natl Compr Canc Netw. 2022-4
J Natl Compr Canc Netw. 2016-3
Front Oncol. 2025-7-16